1. Comparison of gepant effects at therapeutic plasma concentrations: connecting pharmacodynamics and pharmacokinetics.
- Author
-
Boucherie DM, Dammers R, Vincent A, Danser AHJ, and MaassenVanDenBrink A
- Subjects
- Humans, Male, Meningeal Arteries drug effects, Adult, Female, Calcitonin Gene-Related Peptide Receptor Antagonists pharmacokinetics, Calcitonin Gene-Related Peptide Receptor Antagonists administration & dosage, Calcitonin Gene-Related Peptide Receptor Antagonists pharmacology, Middle Aged, Azepines pharmacokinetics, Azepines administration & dosage, Azepines pharmacology, Migraine Disorders drug therapy, Migraine Disorders blood, Calcitonin Gene-Related Peptide blood, Calcitonin Gene-Related Peptide pharmacokinetics, Administration, Intranasal
- Abstract
Background: Orally administered second-generation gepants are effective for the treatment of migraine. The intranasal administration of the third-generation gepant zavegepant might have additional benefits including a rapid onset of action, but it is not clear yet to which extent this has clinical relevance., Methods: We examined the effect of zavegepant on the relaxations induced by calcitonin gene-related peptide (CGRP) in human isolated middle meningeal arteries. Furthermore, we connected the pharmacodynamics and pharmacokinetics of gepants by combining data from clinical and basic research., Results: We showed that 10 nM zavegepant potently antagonized the functional response to CGRP. We also showed that all gepants are effective at inhibiting functional responses to CGRP at their therapeutic plasma concentrations., Conclusions: The relatively low predicted potency of zavegepant to inhibit CGRP-induced relaxation at therapeutic systemic plasma concentrations may point to the relevance of local delivery to the trigeminovascular system through intranasal administration. This approach may have additional benefits for various groups of patients, including overweight patients., (© 2024. The Author(s).)
- Published
- 2024
- Full Text
- View/download PDF